Table 2.
Characteristics of remnant pancreatic cancer
| Remnant operation | |||||||
|---|---|---|---|---|---|---|---|
| No | DFI | Treatment | Differentiation | UICC | Stage | Prognosis(after 2nd operation) | Recurrence form |
| 1 | 20 years | BSC(resection impossible) | (−) | Death(6 m) | Peritoneum | ||
| 2 | 11 year 11 month | Remnant pancreas resection+PV | Moderately | T3N1M0 | IIB | Death(11 month) | Peritoneum |
| 3 | 9 year 5 month | Chemotherapy(resection possible) | (−) | Death(3 year) | Liver, peritoneum | ||
| 4 | 10 year 1 month | Chemotherapy(resection possible) | (−) | Death(1 year 4 month) | Liver, peritoneum | ||
| 5 | 10 year 2 month | BSC(resection impossible) | (−) | Death(6 month) | Liver, peritoneum | ||
| 6 | 9 year 9 month | BSC(resection impossible) | (−) | Death(2 month) | Liver, peritoneum, lung | ||
| 7 | 9 year 2 month | Remnant pancreas resection+remnant stomach resection+IOR | Moderately | T3N1M0 | IIB | Death(4 month) | Pleura |
| 8 | 5 year 8 month | Remnant pancreas resection | Well | T1N0M0 | IA | Alive(7 year) | (−) |
| 9 | 6 year 3 month | Remnant pancreas resection | Moderately | T3N0M0 | IIA | Alive(1 year 3 month) | (−) |
| 10 | 4 year 5 month | Chemotherapy(resection possible) | (−) | Death(1 year 6 month) | Liver, peritoneum | ||
| 11 | 2 year 5 month | Chemotherapy(resection possible) | (−) | Death(9 month) | Liver, peritoneum | ||
| 12 | 2 year 5 month | Remnant pancreas resection | Moderately | T3N0M0 | IIA | Death(2 year 1 month) | Liver |
| 13 | 3 year5 month | BSC(resection possible) | (−) | Death(10 month) | Liver, peritoneum | ||
| 14 | 3 year 3 month | Remnant pancreas resection+PV | Well | T3N1M0 | IIB | Death(2 year 6 month) | Liver, lung |
| 15 | 2 year 9 month | Remnant pancreas resection | Poorly | T3N0M0 | IIA | Alive(7 year 6 month) | (−) |
| 16 | 2 year 6 month | Remnant pancreas resection+remnant stomach resection | IPMC | TisN0M0 | 0 | Alive(8 month) | (−) |
| 17 | 1year 3month | DP | Moderately | T3N1M0 | IIB | Alive(3 year) | Peritoneum |
| 18 | 2 year 7 month | DPPHR | IPMC | TisN0M0 | 0 | Alive(3 year 8 month) | (−) |
| 19 | 2year 9 month | Chemoradiotherapy(resection impossible) | (−) | Death(12 month) | Peritoneum | ||
| 20 | 2 year 8 month | Remnant pancreas resection | Moderately | T3N1M0 | IIB | Alive(6 month) | (−) |
| 21 | 13 year 1 month | Chemoradiotherapy(resection impossible) | (−) | Dead(4 year 5 month) | Peritoneum | ||
| 22 | 1 year 6 month | BSC(resection possible) | (−) | Dead(2 year 2 month) | Peritoneum | ||
| 23 | 5 year 2 month | Remnant pancreas resection | Moderately | T3N1M0 | IIB | Alive(1 month) | (−) |
DFI disease free interval PD pancreaticoduodenectomy, DP distal pancreatectomy, PPPD pylorus preserving PD, PV portal vein resection and reconstruction, DPPHR duodenum preserving pancreas head resection, y year, m month, IOR intraoperative radiation, BSC best supportive care, SSPPD subtotal stomach preserving pancreaticoduodenectomy, IPMC intraductal papillary mucinous carcinoma IOR intraoperative radiation therapy